Myths vs facts: Östradiol and longevity

The relationship between estradiol (E2) and longevity is complex and sex-dependent. In women, premenopausal E2 is protective for cardiovascular health, bone density, and cognition, which may contribute to longer life expectancy. After menopause, E2 drops sharply, increasing chronic disease risk. Hormone replacement therapy (HRT) with estradiol can mitigate these risks but also carries potential harms (e.g., breast cancer, thromboembolism) depending on timing, duration, and formulation. In men, moderate E2 levels are important for bone metabolism and libido; both excess and deficiency are linked to metabolic issues. Evidence from observational studies is moderate, but long-term randomized trials on longevity are lacking. Consumer estradiol tests (saliva or blood) can measure current levels but are not diagnostic without clinical context. Bottom line: estradiol is one piece of the longevity puzzle; any intervention should be medically supervised. There is no simple 'longevity boost' from estradiol alone.